- call +1-201-465-4211
- email sales@mrinsights.biz
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
The classification of Tumor Ablation includes Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation and others. The proportion of Radiofrequency (RF) Ablation in 2015 is about 50.6%, and the proportion of Microwave Ablation in 2015 is about 21.7%.
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2015 is about 28.5%.
According to this study, over the next five years the Tumor Ablation market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Tumor Ablation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Ablation market by product type, application, key manufacturers and key regions and countries.
This study considers the Tumor Ablation value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Liver Cancer
Lung Cancer
Kidney Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Angiodynamics
Medtronic
Boston Scientific
Galil Medical
Neuwave Medical
Misonix
Merit Medical
Sonacare Medical
EDAP TMS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Tumor Ablation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Tumor Ablation market by identifying its various subsegments.
Focuses on the key global Tumor Ablation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tumor Ablation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Tumor Ablation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Tumor Ablation Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Ablation Consumption 2014-2024
2.1.2 Tumor Ablation Consumption CAGR by Region
2.2 Tumor Ablation Segment by Type
2.2.1 Radiofrequency (RF) Ablation
2.2.2 Microwave Ablation
2.2.3 Cryoablation
2.2.4 Other Technologies
2.3 Tumor Ablation Consumption by Type
2.3.1 Global Tumor Ablation Consumption Market Share by Type (2014-2019)
2.3.2 Global Tumor Ablation Revenue and Market Share by Type (2014-2019)
2.3.3 Global Tumor Ablation Sale Price by Type (2014-2019)
2.4 Tumor Ablation Segment by Application
2.4.1 Liver Cancer
2.4.2 Lung Cancer
2.4.3 Kidney Cancer
2.4.4 Others
2.5 Tumor Ablation Consumption by Application
2.5.1 Global Tumor Ablation Consumption Market Share by Application (2014-2019)
2.5.2 Global Tumor Ablation Value and Market Share by Application (2014-2019)
2.5.3 Global Tumor Ablation Sale Price by Application (2014-2019)
3 Global Tumor Ablation by Players
3.1 Global Tumor Ablation Sales Market Share by Players
3.1.1 Global Tumor Ablation Sales by Players (2017-2019)
3.1.2 Global Tumor Ablation Sales Market Share by Players (2017-2019)
3.2 Global Tumor Ablation Revenue Market Share by Players
3.2.1 Global Tumor Ablation Revenue by Players (2017-2019)
3.2.2 Global Tumor Ablation Revenue Market Share by Players (2017-2019)
3.3 Global Tumor Ablation Sale Price by Players
3.4 Global Tumor Ablation Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Tumor Ablation Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Tumor Ablation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Tumor Ablation by Regions
4.1 Tumor Ablation by Regions
4.1.1 Global Tumor Ablation Consumption by Regions
4.1.2 Global Tumor Ablation Value by Regions
4.2 Americas Tumor Ablation Consumption Growth
4.3 APAC Tumor Ablation Consumption Growth
4.4 Europe Tumor Ablation Consumption Growth
4.5 Middle East & Africa Tumor Ablation Consumption Growth
5 Americas
5.1 Americas Tumor Ablation Consumption by Countries
5.1.1 Americas Tumor Ablation Consumption by Countries (2014-2019)
5.1.2 Americas Tumor Ablation Value by Countries (2014-2019)
5.2 Americas Tumor Ablation Consumption by Type
5.3 Americas Tumor Ablation Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Tumor Ablation Consumption by Countries
6.1.1 APAC Tumor Ablation Consumption by Countries (2014-2019)
6.1.2 APAC Tumor Ablation Value by Countries (2014-2019)
6.2 APAC Tumor Ablation Consumption by Type
6.3 APAC Tumor Ablation Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Tumor Ablation by Countries
7.1.1 Europe Tumor Ablation Consumption by Countries (2014-2019)
7.1.2 Europe Tumor Ablation Value by Countries (2014-2019)
7.2 Europe Tumor Ablation Consumption by Type
7.3 Europe Tumor Ablation Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Tumor Ablation by Countries
8.1.1 Middle East & Africa Tumor Ablation Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Tumor Ablation Value by Countries (2014-2019)
8.2 Middle East & Africa Tumor Ablation Consumption by Type
8.3 Middle East & Africa Tumor Ablation Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tumor Ablation Distributors
10.3 Tumor Ablation Customer
11 Global Tumor Ablation Market Forecast
11.1 Global Tumor Ablation Consumption Forecast (2019-2024)
11.2 Global Tumor Ablation Forecast by Regions
11.2.1 Global Tumor Ablation Forecast by Regions (2019-2024)
11.2.2 Global Tumor Ablation Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Tumor Ablation Forecast by Type
11.8 Global Tumor Ablation Forecast by Application
12 Key Players Analysis
12.1 Angiodynamics
12.1.1 Company Details
12.1.2 Tumor Ablation Product Offered
12.1.3 Angiodynamics Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Angiodynamics News
12.2 Medtronic
12.2.1 Company Details
12.2.2 Tumor Ablation Product Offered
12.2.3 Medtronic Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Medtronic News
12.3 Boston Scientific
12.3.1 Company Details
12.3.2 Tumor Ablation Product Offered
12.3.3 Boston Scientific Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Boston Scientific News
12.4 Galil Medical
12.4.1 Company Details
12.4.2 Tumor Ablation Product Offered
12.4.3 Galil Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Galil Medical News
12.5 Neuwave Medical
12.5.1 Company Details
12.5.2 Tumor Ablation Product Offered
12.5.3 Neuwave Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Neuwave Medical News
12.6 Misonix
12.6.1 Company Details
12.6.2 Tumor Ablation Product Offered
12.6.3 Misonix Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Misonix News
12.7 Merit Medical
12.7.1 Company Details
12.7.2 Tumor Ablation Product Offered
12.7.3 Merit Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Merit Medical News
12.8 Sonacare Medical
12.8.1 Company Details
12.8.2 Tumor Ablation Product Offered
12.8.3 Sonacare Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Sonacare Medical News
12.9 EDAP TMS
12.9.1 Company Details
12.9.2 Tumor Ablation Product Offered
12.9.3 EDAP TMS Tumor Ablation Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 EDAP TMS News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Tumor Ablation
Table Product Specifications of Tumor Ablation
Figure Tumor Ablation Report Years Considered
Figure Market Res
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
